Contemporary Progress and Opportunities in RNA-Targeted Drug Discovery
- 23 February 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 14 (3) , 251-259
Abstract
The surprising discovery that RNAs are the predominant gene products to emerge from the human genome catalyzed a renaissance in RNA biology. It is now well-understood that RNAs act as more than just a messenger and comprise a large and diverse family of ribonucleic acids of differing sizes, structures, and functions. RNAs play expansive roles in the cell, contributing to the regulation and fine-tuning of nearly all aspects of gene expression and genome architecture. In line with the significance of these functions, we have witnessed an explosion in discoveries connecting RNAs with a variety of human diseases. Consequently, the targeting of RNAs, and more broadly RNA biology, has emerged as an untapped area of drug discovery, making the search for RNA-targeted therapeutics of great interest. In this Microperspective, I highlight contemporary learnings in the field and present my views on how to catapult us toward the systematic discovery of RNA-targeted medicines.Keywords
Funding Information
- Dr. Ralph and Marian Falk Medical Research Trust
- National Institute of General Medical Sciences (R01 GM135252)
This publication has 119 references indexed in Scilit:
- Landscape of transcription in human cellsNature, 2012
- Identifying the preferred RNA motifs and chemotypes that interact by probing millions of combinationsNature Communications, 2012
- Defining the RNA Internal Loops Preferred by Benzimidazole Derivatives via 2D Combinatorial Screening and Computational AnalysisJournal of the American Chemical Society, 2011
- Molecular Recognition of 6′-N-5-Hexynoate Kanamycin A and RNA 1x1 Internal Loops Containing CA MismatchesBiochemistry, 2011
- A modified fluorescent intercalator displacement assay for RNA ligand discoveryAnalytical Biochemistry, 2011
- Structure–Activity Relationships through Sequencing (StARTS) Defines Optimal and Suboptimal RNA Motif Targets for Small MoleculesAngewandte Chemie International Edition, 2010
- Two-Dimensional Combinatorial Screening of a Bacterial rRNA A-Site-like Motif Library: Defining Privileged Asymmetric Internal Loops That Bind AminoglycosidesBiochemistry, 2010
- Two-dimensional combinatorial screening and the RNA Privileged Space Predictor program efficiently identify aminoglycoside–RNA hairpin loop interactionsNucleic Acids Research, 2009
- Rational Design of Ligands Targeting Triplet Repeating Transcripts That Cause RNA Dominant Disease: Application to Myotonic Muscular Dystrophy Type 1 and Spinocerebellar Ataxia Type 3Journal of the American Chemical Society, 2009
- Two-Dimensional Combinatorial Screening Identifies Specific 6′-Acylated Kanamycin A− and 6′-Acylated Neamine−RNA Hairpin InteractionsBiochemistry, 2008